Home Molecular Dx Pharmacogenomic Testing

Pharmacogenomic Testing

Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching
Leukemia

Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching

0
Four Genetic Variants Linked to Drug-Induced Fatal Brain Infection
Molecular Dx

Four Genetic Variants Linked to Drug-Induced Fatal Brain Infection

0
PacBio, Twist Launch Off-the-Shelf Long-Read Panel Line
Molecular Dx

PacBio, Twist Launch Off-the-Shelf Long-Read Panel Line

0
Genetics Can Impact How Effective Psychedelic Drugs Are at Treating Neurological Conditions
Genetic Disorders

Genetics Can Impact How Effective Psychedelic Drugs Are at Treating Neurological Conditions

0
Pharmacogenetic Testing Could Improve Outcomes for Patients with Depression
Molecular Dx

Pharmacogenetic Testing Could Improve Outcomes for Patients with Depression

0
Avera Health, Sema4 Launch Joint Five-Year Precision Oncology Study
Artificial Intelligence

Avera Health, Sema4 Launch Joint Five-Year Precision Oncology Study

0
Michigan Blue Taps OneOme for Pharmacogenomics Pilot Program
Molecular Dx

Michigan Blue Taps OneOme for Pharmacogenomics Pilot Program

0
Castle Biosciences to Acquire Mental Health PGx Test Maker AltheaDx
Mental Health Disorders

Castle Biosciences to Acquire Mental Health PGx Test Maker AltheaDx

0
Leading PGx Resources Show Incongruous Gene-Drug Interactions, Dosing Recommendations
Molecular Dx

Leading PGx Resources Show Incongruous Gene-Drug Interactions, Dosing Recommendations

0
Mayo and Baylor Study Supports Preemptive Gene Testing
Molecular Dx

Mayo and Baylor Study Supports Preemptive Gene Testing

0
123...5Page 1 of 5

Trending

Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy

Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy

Study Defines Four Distinct Phenotypes of Long COVID

Study Defines Four Distinct Phenotypes of Long COVID

Rare Mutations Confer Risk of Common Diseases

Rare Mutations Confer Risk of Common Diseases

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine